Benralizumab, an anti-interleukin-5 receptor [alpha] monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

FitzGerald, J Mark ; Bleecker, Eugene R ; Nair, Parameswaran ; Korn, Stephanie ; Ohta, Ken ; Lommatzsch, Marek ; Ferguson, Gary T ; Busse, William W ; Barker, Peter ; Sproule, Stephanie ; Gilmartin, Geoffrey ; Werkström, Viktoria ; Aurivillius, Magnus ; Goldman, Mitchell

The Lancet (British edition), 2016-10, Vol.388 (10056), p.2128 [Periódico revisado por pares]

London: Elsevier Limited

Texto completo disponível